Skelbimas
|
Skelbimų sritys
|
Weight Loss Peptides Tirzepatide CAS 2023788-19-2Skelbimo nr. 298074, įdėtas 2025-04-21 · Perskaitė: 28
Tirzepatide uniquely activates both GIP and GLP-1 receptors, enhancing insulin secretion, suppressing glucagon release, and delaying gastric emptying. This dual action synergistically reduces appetite, promotes satiety, and improves metabolic functions, leading to significant weight loss and glycemic control
Kaina: 30 EUR 
 Kiti skelbimai iš kategorijos "Grožis, sveikata" |
Kontaktai
|
